Successful cochlear implant surgery for four-year-old Angelo aids hearing, part of a charitable initiative by Care and Share Foundation.

A cochlear implant, a small yet complex electronic device, is emerging as a transformative solution for individuals with severe hearing loss, enabling them to perceive sound and significantly improve ...

Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...

The medical device manufacturer has delivered a bitter pill for shareholders. The post Why are Cochlear shares down 36% today ...

Investors today birched Cochlear shares by close to 40% after a radical earnings update – their worst fall in 30 years.

Cochlear isn’t selling hearing implants like it thought it could or should. It’s been a problem throughout its whole ...

Cochlear reduces its FY26 earnings guidance amid softer implant sales, ongoing challenges in key markets, and a focus on long ...

Cochlear Ltd., an Australian implantable hearing devices company, saw its shares drop by 40% after slashing its full-year ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss ...

Key Takeaways Otarmeni, a gene therapy targeting a specific mutation that causes profound deafness, now has U.S. Food and ...

April 22 () - Cochlear shares crashed nearly 41% on Wednesday in a record daily fall, after the Australian hearing implants maker slashed its forecast ‌for annual earnings, citing weak trading ...

Cochlear also said that trading conditions for implants in developed markets have been softer-than-expected, while the fourth ...